Breda M. Twomey

823 total citations
22 papers, 688 citations indexed

About

Breda M. Twomey is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Breda M. Twomey has authored 22 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Immunology and 5 papers in Oncology. Recurrent topics in Breda M. Twomey's work include Heat shock proteins research (6 papers), thermodynamics and calorimetric analyses (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). Breda M. Twomey is often cited by papers focused on Heat shock proteins research (6 papers), thermodynamics and calorimetric analyses (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). Breda M. Twomey collaborates with scholars based in United Kingdom, Hong Kong and Malta. Breda M. Twomey's co-authors include M.Maureen Dale, David Isenberg, Stewart W. McCallum, D.S. Latchman, Sandra E. Wilkinson, John Nixon, Dalya R. Soond, A. D. Sedgwick, Kjetil Taskén and J. S. Hill Gaston and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Breda M. Twomey

21 papers receiving 677 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Breda M. Twomey 382 277 127 78 67 22 688
Yanwen Zhou 394 1.0× 119 0.4× 158 1.2× 21 0.3× 43 0.6× 34 618
Yvonne Vercoulen 482 1.3× 340 1.2× 156 1.2× 27 0.3× 44 0.7× 25 944
Max Hamaker 795 2.1× 117 0.4× 111 0.9× 45 0.6× 70 1.0× 9 1.1k
Stephan Geley 634 1.7× 168 0.6× 185 1.5× 43 0.6× 40 0.6× 16 879
Minerva Fernandez 860 2.3× 202 0.7× 132 1.0× 28 0.4× 146 2.2× 12 1.3k
Alessandro Arcucci 465 1.2× 181 0.7× 378 3.0× 25 0.3× 30 0.4× 35 948
Patrick Bhola 467 1.2× 89 0.3× 184 1.4× 49 0.6× 31 0.5× 15 820
Evelyn Aranda 412 1.1× 106 0.4× 210 1.7× 29 0.4× 41 0.6× 12 753
María C. Castellanos 481 1.3× 125 0.5× 137 1.1× 30 0.4× 68 1.0× 11 807
Fatima Bouali 541 1.4× 221 0.8× 166 1.3× 19 0.2× 207 3.1× 14 959

Countries citing papers authored by Breda M. Twomey

Since Specialization
Citations

This map shows the geographic impact of Breda M. Twomey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Breda M. Twomey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Breda M. Twomey more than expected).

Fields of papers citing papers by Breda M. Twomey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Breda M. Twomey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Breda M. Twomey. The network helps show where Breda M. Twomey may publish in the future.

Co-authorship network of co-authors of Breda M. Twomey

This figure shows the co-authorship network connecting the top 25 collaborators of Breda M. Twomey. A scholar is included among the top collaborators of Breda M. Twomey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Breda M. Twomey. Breda M. Twomey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barnouin, Karin, Elisa Tonoli, Clare Coveney, et al.. (2025). Identification of mechanistic CKD biomarkers in a rat SNx kidney fibrosis model by transcriptomics and proteomics detectable in biofluids. Scientific Reports. 15(1). 11200–11200.
2.
Huang, Linghong, Hélène Bon, Mabrouka Maamra, et al.. (2024). The effect of TG2-inhibitory monoclonal antibody zampilimab on tissue fibrosis in human in vitro and primate in vivo models of chronic kidney disease. PLoS ONE. 19(5). e0298864–e0298864. 3 indexed citations
3.
Bon, Hélène, Paul Hales, Simon Lumb, et al.. (2019). Spontaneous Extracellular Matrix Accumulation in a Human in vitro Model of Renal Fibrosis Is Mediated by αV Integrins. ˜The œNephron journals/Nephron journals. 142(4). 328–350. 29 indexed citations
4.
Holdsworth, Gill, Hélène Bon, Marianne Bergin, et al.. (2017). Quantitative and organisational changes in mature extracellular matrix revealed through high-content imaging of total protein fluorescently stained in situ. Scientific Reports. 7(1). 9963–9963. 8 indexed citations
5.
Allen, Rodger A., Mark Powell, Gareth Davies, et al.. (2017). Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3Kδ. Journal of Pharmacology and Experimental Therapeutics. 361(3). 429–440. 35 indexed citations
6.
Qureshi, Omar, Hélène Bon, Breda M. Twomey, et al.. (2017). An immunofluorescence assay for extracellular matrix components highlights the role of epithelial cells in producing a stable, fibrillar extracellular matrix. Biology Open. 6(10). 1423–1433. 30 indexed citations
7.
Soond, Dalya R., Elisa Bjørgo, Kristine Moltu, et al.. (2010). PI3K p110δ regulates T-cell cytokine production during primary and secondary immune responses in mice and humans. Blood. 115(11). 2203–2213. 161 indexed citations
8.
Yung, Lisa Y., et al.. (2008). Differential involvement of Gα16 in CC chemokine-induced stimulation of phospholipase Cβ, ERK, and chemotaxis. Cellular Signalling. 20(6). 1179–1189. 21 indexed citations
9.
New, David C., Lisa Y. Yung, Rodger A. Allen, et al.. (2004). Differential chemokine activation of CC chemokine receptor 1‐regulated pathways: ligand selective activation of Gα 14‐coupled pathways. European Journal of Immunology. 34(3). 785–795. 31 indexed citations
10.
Huntriss, John, Breda M. Twomey, David Isenberg, & David S. Latchman. (1994). Enhanced Transcription of the Gene Encoding the Smn Autoantigen in Patients with Systemic Lupus Erythematosus Does not Result in Enhanced Levels of the SMN Protein. Autoimmunity. 19(2). 81–87. 2 indexed citations
11.
McCallum, Stewart W., et al.. (1993). THE DIFFERENTIAL EXPRESSION OF HEAT SHOCK PROTEINS IN RHEUMATIC DISEASE. Lara D. Veeken. 32(10). 883–892. 11 indexed citations
13.
Twomey, Breda M., Stewart W. McCallum, David Isenberg, & D.S. Latchman. (1993). Elevation of heat shock protein synthesis and hsp gene transcription during monocyte to macrophage differentiation of U937 cells. Clinical & Experimental Immunology. 93(2). 178–183. 40 indexed citations
14.
Twomey, Breda M., Vaksha Amin, David Isenberg, & David S. Latchman. (1993). Elevated Levels of the 70 kD Heat Shock Protein in Patients with Systemic Lupus Erythematosus are not Dependent on Enhanced Transcription of the hsp70 Gene. Lupus. 2(5). 297–301. 6 indexed citations
15.
Twomey, Breda M. & M.Maureen Dale. (1992). Cyclooxygenase-independent effects of nonsteroidal anti-inflammatory drugs on the neutrophil respiratory burst. Biochemical Pharmacology. 43(3). 413–418. 38 indexed citations
16.
17.
Dale, M.Maureen, Peter D. Davis, Lucy H. Elliott, et al.. (1991). A novel conformationally restricted protein kinase C inhibitor, Ro 31‐8425, inhibits human neutrophil superoxide generation by soluble, particulate and post‐receptor stimuli. FEBS Letters. 293(1-2). 169–172. 52 indexed citations
19.
Twomey, Breda M., et al.. (1990). The effect of new potent selective inhibitors of protein kinase C on the neutrophil respiratory burst. Biochemical and Biophysical Research Communications. 171(3). 1087–1092. 71 indexed citations
20.
Twomey, Breda M., et al.. (1988). The effect of inhibition of both diacylglycerol metabolism and phospholipase A2 activity on superoxide generation by human neutrophils. FEBS Letters. 234(1). 235–240. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026